These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 101143)

  • 1. Isolation of plasminogen activator from human plasma by chromatography on lysine-sepharose.
    Radcliffe R; Heinze T
    Arch Biochem Biophys; 1978 Jul; 189(1):185-94. PubMed ID: 101143
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
    Husain SS; Lipinski B; Greuwich V
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of tissue activator and urokinase by human plasma.
    Walker JE; Ogston D
    Thromb Haemost; 1982 Jun; 47(3):265-8. PubMed ID: 6180497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of plasminogen activator from human uterine tissue.
    Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
    Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.
    Kacian DL; Harvey RC
    Arch Biochem Biophys; 1985 Jan; 236(1):354-69. PubMed ID: 2981508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stability of tissue plasminogen activator].
    Liutova LV; Andreenko GV; Shimonaeva EE
    Vopr Med Khim; 1985; 31(1):97-9. PubMed ID: 3920826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
    Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
    Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of plasminogen activators from human seminal plasma.
    Propping D; Zaneveld LJ; Tauber PF; Schumacher GF
    Biochem J; 1978 May; 171(2):435-44. PubMed ID: 26336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and properties of human vascular plasminogen activator.
    Allen RA; Pepper DS
    Thromb Haemost; 1981 Feb; 45(1):43-50. PubMed ID: 7195611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human plasma plasminogen activator].
    Batista Diaz A
    Probl Gematol Pereliv Krovi; 1982; 27(1):40-4. PubMed ID: 6801643
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet release protein which inhibits plasminogen activators.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1985 Jul; 38(7):825-30. PubMed ID: 3926830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification and some properties of the tissue plasminogen activator from the human myometrium.
    Soszka T
    Thromb Res; 1977 Jun; 10(6):823-32. PubMed ID: 18814
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I; Thorsen S; Müllertz S
    Haemostasis; 1976; 5(4):218-30. PubMed ID: 826461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.
    Kaltoft K; Nielsen LS; Zeuthen J; Danø K
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3720-3. PubMed ID: 6808514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
    Sudol M; Reich E
    Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of epidermal plasminogen activator inhibitor.
    Hibino T; Izaki S; Izaki M
    FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
    Wiman B; Lindahl T; Almqvist A
    Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.
    Binder BR; Spragg J; Austen KF
    J Biol Chem; 1979 Mar; 254(6):1998-2003. PubMed ID: 106053
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a plasma membrane-associated plasminogen activator on thymocytes.
    Fulton RJ; Hart DA
    Biochim Biophys Acta; 1981 Apr; 642(2):345-64. PubMed ID: 6793069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.